The COVID-19 pandemic created a dangerous cascade of measles vulnerability that extends far beyond missed vaccinations, fundamentally altering how mothers protect their newborns. This finding challenges assumptions about measles immunity recovery and reveals why some children face dramatically higher infection risks than others.

Analysis of 15,405 antibody measurements from southern China spanning 2013-2024 reveals that women born during periods of reduced measles circulation (1990-2005) carry 0.39 log mIU/ml lower antibody concentrations compared to those born during high-transmission years. These mothers transfer correspondingly weaker immunity to their infants, who lose protective antibodies 0.29 log faster than babies born to mothers with naturally-acquired immunity. Additionally, 9.5-10.7% of pediatric susceptibility stems from vaccine-induced immunity naturally declining over time.

This research illuminates a critical blind spot in measles control strategies. The generation of mothers now bearing children lived through an era when successful vaccination programs had already reduced wild measles circulation, limiting their exposure to immunity-boosting infections. Unlike their predecessors who gained robust, long-lasting immunity through natural infection, these mothers possess primarily vaccine-derived protection that wanes more rapidly and transfers less effectively to offspring.

The implications extend well beyond individual families. Mathematical modeling suggests non-selective supplementary immunization campaigns could boost population immunity from 66.6% to 92.7% in children under 15, representing a 23.5-50% improvement. However, this represents a reactive rather than preventive approach. The findings suggest that maintaining measles elimination requires rethinking immunity maintenance across generations, not just catching up on missed doses. As more countries achieve initial measles control, they may inadvertently create similar intergenerational immunity gaps unless surveillance and supplementation strategies account for these maternal immunity dynamics.